Viatris Inc. reports results for the quarter ended September 30 - Earnings Summary

• Viatris Inc. reported quarterly adjusted earnings of 71 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 67 cents. The mean expectation of ten analysts for the quarter was for earnings of 64 cents per share. Wall Street expected results to range from 62 cents to 66 cents per share.

• Revenue fell 0.3% to $3.75 billion from a year ago; analysts expected $3.79 billion.

• Viatris Inc.'s reported EPS for the quarter was a loss of 28 cents​.

• The company reported a quarterly loss of $325.3 million.

• Viatris Inc. shares had risen by 8.5% this quarter and gained 54.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.2% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Viatris Inc. is $20.00, about 3.9% above its last closing price of $19.22

This summary was machine generated from LSEG data November 5 at 06:09 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)